Cell expressing car and gpcr
AssigneeUCL Business PLC
InventorsMartin Pulé, Paul Maciocia, Khai Kong
Life of this patent
Estimating the term…
Loading patent…
AssigneeUCL Business PLC
InventorsMartin Pulé, Paul Maciocia, Khai Kong
Estimating the term…
The present invention provides a cell which co-expresses (i) a chimeric antigen receptor (CAR) and a GPCR at the cell surface and (ii) an intracellular component comprising a protease domain linked to a GPCR-targeting domain; wherein an intracellular domain of the GPCR comprises a protease cleavage site linked to a transcriptional regulatory domain, which transcriptional regulatory domain is capable of modulating the expression of a nucleic acid encoding the CAR; and wherein the protease domain of the intracellular component is capable of cleaving the cleavage site; such that, upon binding of ligand to the GPCR, the intracellular component is recruited to the GPCR and the protease domain cleaves the cleavage site thereby releasing the transcriptional regulatory domain from the GPCR.
A cell which co-expresses (i) a chimeric antigen receptor (CAR) and a G-protein coupled receptor (GPCR) at the cell surface and (ii) an intracellular component comprising a protease domain linked to a GPCR-targeting domain;
A cell according to any preceding claim wherein the protease domain comprises a Tobacco Etch Virus protease, a furin protease, a tobacco vein mottling virus (TVMV) protease or a plum pox virus Nia protease.
A cell according to any preceding claim wherein the GPCR-targeting domain comprises an arrestin domain.
Dependencies are inferred from the claim text.